Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU. Goodwin GM, et al. Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Eur Neuropsychopharmacol. 2008. PMID: 18501566 Review.
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network.
Kessing LV, González-Pinto A, Fagiolini A, Bechdolf A, Reif A, Yildiz A, Etain B, Henry C, Severus E, Reininghaus EZ, Morken G, Goodwin GM, Scott J, Geddes JR, Rietschel M, Landén M, Manchia M, Bauer M, Martinez-Cengotitabengoa M, Andreassen OA, Ritter P, Kupka R, Licht RW, Nielsen RE, Schulze TG, Hajek T, Lagerberg TV, Bergink V, Vieta E. Kessing LV, et al. Among authors: goodwin gm. Eur Neuropsychopharmacol. 2021 Jun;47:54-61. doi: 10.1016/j.euroneuro.2021.01.097. Epub 2021 Feb 2. Eur Neuropsychopharmacol. 2021. PMID: 33541809 Review.
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M. Tohen M, et al. Among authors: goodwin gm. Bipolar Disord. 2009 Aug;11(5):453-73. doi: 10.1111/j.1399-5618.2009.00726.x. Bipolar Disord. 2009. PMID: 19624385 Review.
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action.
Manchia M, Vieta E, Smeland OB, Altimus C, Bechdolf A, Bellivier F, Bergink V, Fagiolini A, Geddes JR, Hajek T, Henry C, Kupka R, Lagerberg TV, Licht RW, Martinez-Cengotitabengoa M, Morken G, Nielsen RE, Pinto AG, Reif A, Rietschel M, Ritter P, Schulze TG, Scott J, Severus E, Yildiz A, Kessing LV, Bauer M, Goodwin GM, Andreassen OA; European College of Neuropsychopharmacology (ECNP) Bipolar Disorders Network. Manchia M, et al. Among authors: goodwin gm. Eur Neuropsychopharmacol. 2020 Jul;36:121-136. doi: 10.1016/j.euroneuro.2020.05.006. Epub 2020 Jun 12. Eur Neuropsychopharmacol. 2020. PMID: 32536571 Free article. Review.
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.
Similon MVM, Paasche C, Krol F, Lerer B, Goodwin GM, Berk M, Meyer-Lindenberg A, Ketter TA, Yatham LN, Goldberg JF, Malhi GS, El-Mallakh R, Licht RW, Young AH, Kapczinski F, Swartz M, Hagin M, Torrent C, Serretti A, Yildiz A, Martínez-Arán A, Strejilevich S, Rybakowski J, Sani G, Grunze H, Vázquez G, Pinto AG, Azorin JM, Nolen W, Sentissi O, López-Jaramillo C, Frey BN, Nierenberg A, Parker G, Bond DJ, Cohen A, Tortorella A, Perugi G, Vieta E, Popovic D. Similon MVM, et al. Among authors: goodwin gm. Eur Neuropsychopharmacol. 2022 Jul;60:91-99. doi: 10.1016/j.euroneuro.2022.05.002. Epub 2022 Jun 2. Eur Neuropsychopharmacol. 2022. PMID: 35665655
458 results